| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/05/2004 | WO2004011647A1 Modified small interfering rna molecules and methods of use |
| 02/05/2004 | WO2004011640A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 02/05/2004 | WO2004011635A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis |
| 02/05/2004 | WO2004011632A2 Oligodendrocyte production from multipotent neural stem cells |
| 02/05/2004 | WO2004011631A2 Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus |
| 02/05/2004 | WO2004011630A2 Biomimetic urothelium |
| 02/05/2004 | WO2004011629A2 Immortalized colon epithelial cells and the use thereof |
| 02/05/2004 | WO2004011622A2 Methods for perfusion and plating of primary hepatocytes and a medium therefore |
| 02/05/2004 | WO2004011621A2 Multi-step method for the differentiation of insulin positive, glucose |
| 02/05/2004 | WO2004011611A2 Taci antibodies and uses thereof |
| 02/05/2004 | WO2004011603A2 Functional cardiomyocytes from human embryonic stem cells |
| 02/05/2004 | WO2004011601A2 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 02/05/2004 | WO2004011598A2 Long lived keratinocytes |
| 02/05/2004 | WO2004011596A2 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 02/05/2004 | WO2004011490A1 A immounlogical epitope of the hiv strain type o and the uses thereof |
| 02/05/2004 | WO2004011484A2 Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion |
| 02/05/2004 | WO2004011098A2 Golf shaft with adjustable stiffness and frequency |
| 02/05/2004 | WO2004011025A1 Plant cell wall loosening activity of group 2/3 allergens of grass pollen |
| 02/05/2004 | WO2004010959A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 02/05/2004 | WO2004010953A2 Implantable artificial organ devices |
| 02/05/2004 | WO2004010933A2 Insulin-producing cell compositions and related methods |
| 02/05/2004 | WO2004010852A2 Tissue compositions and methods for producing same |
| 02/05/2004 | WO2003097871A3 Marker molecules associated with lung tumors |
| 02/05/2004 | WO2003091380A3 Method for preparing tissue constructs |
| 02/05/2004 | WO2003089624A3 Fc receptor homolog, reagents, and uses thereof |
| 02/05/2004 | WO2003085086A9 Motif-grafted hybrid polypeptides and uses thereof |
| 02/05/2004 | WO2003083038A3 Disruption of the redk gene |
| 02/05/2004 | WO2003082919A3 Ox40r binding agents |
| 02/05/2004 | WO2003076600A3 In vitro maturation of immature human oocytes |
| 02/05/2004 | WO2003076564A3 Tissue-engineered organs |
| 02/05/2004 | WO2003072811A3 The use of ribozymes in the detection of adventitious agents |
| 02/05/2004 | WO2003066091A3 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 02/05/2004 | WO2003062384A3 Stem cell maturation for all tissue types |
| 02/05/2004 | WO2003062264A3 Functional ligand display |
| 02/05/2004 | WO2003059944A3 Gb virus b based replicons and replicon enhanced cells |
| 02/05/2004 | WO2003059272A3 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors |
| 02/05/2004 | WO2003055911A8 Cystine-knot fold protein |
| 02/05/2004 | WO2003052052A3 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 02/05/2004 | WO2003042397A3 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 02/05/2004 | WO2003037172A3 Endothelial-cell binding peptides for diagnosis and therapy |
| 02/05/2004 | WO2003002710A3 Artificial synapse chip interface for electronic prosthetic retina |
| 02/05/2004 | WO2002098355A3 Methods and reagents for diagnosis and treatment of insulin resistance and related conditions |
| 02/05/2004 | WO2002061046A3 Novel nucleic acid and polypeptide molecules |
| 02/05/2004 | US20040025205 Manipulation of plant senescence using an myb gene promoter and cytokinin biosynthesis gene |
| 02/05/2004 | US20040025199 Comprises g-protein couple receptors for identifying modulators of g-protein activity and diagnosis and treatment of infections, nervous system, tumor, autoimmune and inflammatory disorders |
| 02/05/2004 | US20040025198 Composite swine glandular tissue with increased immunological resistance to rejection; tissue engineering and human xenotransplantation |
| 02/05/2004 | US20040025196 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 02/05/2004 | US20040024192 19 human secreted proteins |
| 02/05/2004 | US20040023929 Small molecules for inhibition of function and drug delivery to leukocytes |
| 02/05/2004 | US20040023907 Infection model |
| 02/05/2004 | US20040023877 Plasminogen fragments containing kringle region domains having anti-angiogenic activity and terned angiostatin protein. The plasminogen fragments of the present invention may be used for the treatment of angiogenesis-dependent diseases such as |
| 02/05/2004 | US20040023856 Purified DNA comprising a sequence encoding a B1k chain of laminin. Vector comprising a DNA sequence encoding a B1k protein. |
| 02/05/2004 | US20040023854 Adiponectin and uses thereof |
| 02/05/2004 | US20040023414 Self-assembling peptide surfaces for cell patterning and interactions |
| 02/05/2004 | US20040023392 Use in introducing predetermined change at predetermined location in target gene in living cell; oligodeoxynucleotide is modified by attachment of 3' and 5' blocking substituents such as a 3'-3'linked cytosine nucleotide and a 5' linked dye |
| 02/05/2004 | US20040023391 Using surface-mediated protein transfected cell microarrays to screen polypeptide and enzyme activities; high throughput assay; drug screening |
| 02/05/2004 | US20040023390 Using small interfering RNA sequences for treating neurodegenerative diseases; gene expression inhibition |
| 02/05/2004 | US20040023387 Method of making demineralized bone particles |
| 02/05/2004 | US20040023377 Culturing lymphocyte population for diagnosis, prevention and treatment of allergies, autoimmune and graft rejection disorders |
| 02/05/2004 | US20040023376 Method of making embryoid bodies from primate embryonic stem cells |
| 02/05/2004 | US20040023375 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays |
| 02/05/2004 | US20040023374 Method and apparatus for multi-layer growth of anchorage dependent cells |
| 02/05/2004 | US20040023373 Novel mucosal vascular addressins |
| 02/05/2004 | US20040023370 Nutrient permeable microcapsules comprising shell and inner extracellular matrix for use in tissue engineering seeding and cell transplantation of hepatocytes and mesenchymal stem cells |
| 02/05/2004 | US20040023358 Avian embryo particulate biomass for the production of virus antigens |
| 02/05/2004 | US20040023343 Biosynthetic genes for spinosyn insecticide production |
| 02/05/2004 | US20040023342 Synthesizing polyketide fusion protein comprising acyltransferase domain for use as anthelminthic, insecticide, antitumor, immunosuppressant, fungicidal and/or bactericidal agents |
| 02/05/2004 | US20040023339 Transgenic cell culture for preparing monoclonal antibodies for treatment and prevention of cancer |
| 02/05/2004 | US20040023337 IL-13 mutein proteins, antibodies, compositions, methods and uses |
| 02/05/2004 | US20040023335 IL-17 like molecules and uses thereof |
| 02/05/2004 | US20040023334 Comprises lactoferrin fusion protein for diagnosis, prevention treatment and prognosis of nervous system, respiratory, cardiovascular and/or reproductive system disorders |
| 02/05/2004 | US20040023333 Production of recombinant blood clotting factors in human cell lines |
| 02/05/2004 | US20040023331 Comprises membrane protein for diagnosis, prevention and treatment cell proliferative disorders; tumor detection |
| 02/05/2004 | US20040023326 Comprises inhibitory monoclonal antibody for controlling metabolic processes associated with cytochrome c oxidase/debrisoquine hydroxylase; drug screening and development; competetive binding |
| 02/05/2004 | US20040023324 Nutrient broth for propagating human hematopoietic cells for use in bone marrow transplants |
| 02/05/2004 | US20040023323 Novel cytokine receptors and nucleic acids encoding the same |
| 02/05/2004 | US20040023321 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptides; cancer diagnosis |
| 02/05/2004 | US20040023318 Method of isolating stem cells |
| 02/05/2004 | US20040023307 DNA encoding a novel RG1 polypeptide |
| 02/05/2004 | US20040023291 Comprises insect polypeptide for use in hemolysis and immunosuppression; immunotherapy |
| 02/05/2004 | US20040023278 Sialoadhesin family member-2 (SAF-2) |
| 02/05/2004 | US20040023267 Comprises nucleotide sequences coding cancer associated proteins (CAP) for diagnosis, prevention and treatment of tumors |
| 02/05/2004 | US20040023261 Micelles comprising semiconductor nanocrystals and uses thereof |
| 02/05/2004 | US20040023260 29 human secreted proteins |
| 02/05/2004 | US20040023257 Comprises nucleotide sequences coding proteolytic enzymes for increasing flavor in food, promoting microbiocidal activity, modifying and deprotecting chemical intermediates, synthesis and hydrolysis of cephalosporins |
| 02/05/2004 | US20040023255 Motor proteins and methods for their use |
| 02/05/2004 | US20040023222 Methods and reagents for improved selection of biological materials |
| 02/05/2004 | US20040023203 Heterologous stimulus-gated ion channels and methods of using same |
| 02/05/2004 | US20040023201 Storage solution containing photosensitizer for inactivation of biological contaminants |
| 02/05/2004 | US20040022812 Herpes viruses for immune modulation |
| 02/05/2004 | US20040022802 Surface proteins of Leptospira |
| 02/05/2004 | US20040022801 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 02/05/2004 | US20040022781 Proteins and nucleic acids encoding same |
| 02/05/2004 | US20040022773 Obtaining a biological sample from a mammal; contacting the biological sample with a medium comprising NK-92 or modified NK-92 natural killer cells |
| 02/05/2004 | US20040022772 Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth |
| 02/05/2004 | US20040022771 Injecting or surgically implanting non-bone cells or tissue into one or more bones of a vertebrate; benefiting from the non-bone cells or tissue after receiving nourishment from the blood vessels within the bone |
| 02/05/2004 | US20040022761 Compositions and methods for producing antigen-presenting cells |
| 02/05/2004 | DE10233064A1 gM-negative EHV-Mutanten ohne heterologe Elemente gM-negative EHV mutants without heterologous elements |
| 02/05/2004 | CA2790024A1 Methods and reagents for improved selection of biological materials |
| 02/05/2004 | CA2727782A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |